Zobrazeno 1 - 10
of 17
pro vyhledávání: '"B de la Calle-Riaguas"'
Autor:
MDP Briceño Casado, MD Gil-Sierra, C Moreno Ramos, B de la Calle-Riaguas, CM Cuadros-Martinez
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b279d6522a3dcb3c2c80d1ce12406fc
https://doi.org/10.1136/ejhpharm-2023-eahp.247
https://doi.org/10.1136/ejhpharm-2023-eahp.247
Autor:
MDP Briceño Casado, MD Gil-Sierra, CM Cuadros-Martinez, B De La Calle-Riaguas, R Gavira-Moreno
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c2e413dca323bae0d660ecb25081d78
https://doi.org/10.1136/ejhpharm-2023-eahp.386
https://doi.org/10.1136/ejhpharm-2023-eahp.386
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0761ca3cc45f6d63b1d5bd41322b7d56
https://doi.org/10.1136/ejhpharm-2022-eahp.305
https://doi.org/10.1136/ejhpharm-2022-eahp.305
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4e7fdecbf7b3be55221b743020d307a
https://doi.org/10.1136/ejhpharm-2022-eahp.311
https://doi.org/10.1136/ejhpharm-2022-eahp.311
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a74f83a23f7f8d398ee2c0c65c84091e
https://doi.org/10.1136/ejhpharm-2022-eahp.306
https://doi.org/10.1136/ejhpharm-2022-eahp.306
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5c3d192794752ef06220c89ba0fe1da
https://doi.org/10.1136/ejhpharm-2022-eahp.267
https://doi.org/10.1136/ejhpharm-2022-eahp.267
Autor:
B De La Calle Riaguas, M Guerro-Prado, MDP Briceño-Casado, P Gómez-Espinosa, FJ Juliá-Luna, MD Gil-Sierra
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d16abd2b119bfd9aa19332d31b90824
https://doi.org/10.1136/ejhpharm-2022-eahp.303
https://doi.org/10.1136/ejhpharm-2022-eahp.303
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b55bf6f231712235d6298d14d994a95
https://doi.org/10.1136/ejhpharm-2022-eahp.261
https://doi.org/10.1136/ejhpharm-2022-eahp.261
2SPD-033 Evaluation of docetaxel in low and high burden metastatic hormone sensitive prostate cancer
Autor:
Marina Sánchez-Hidalgo, C Alarcon De La Lastra-Romero, Mdp Briceño-Casado, Gil-Sierra, B De La Calle-Riaguas, EJ Alegre-Del Rey, M Dominguez-Cantero
Publikováno v:
Section 2: Selection, procurement and distribution.
Background and importance Addition of docetaxel to hormonal treatment in low and high burden metastatic hormone sensitive prostate cancer (mHSPC) has raised important issues. There are studies suggesting increased overall survival (OS) in high burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54a2d3d027da7bb7071a3b3255d7e162
https://doi.org/10.1136/ejhpharm-2021-eahpconf.16
https://doi.org/10.1136/ejhpharm-2021-eahpconf.16
Autor:
B De La Calle-Riaguas, Gil-Sierra, Mdp Briceño-Casado, Marina Sánchez-Hidalgo, C Alarcon De La Lastra-Romero, EJ Alegre-Del Rey, M Dominguez-Cantero
Publikováno v:
Section 2: Selection, procurement and distribution.
Background and importance A greater benefit was suggested with early treatment with remdesivir against COVID-19. Aim and objectives To develop a systematic review and methodological interpretation of subgroup analyses according to timing of use of re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8230609fb65b91b338fa15fd2d7812a1
https://doi.org/10.1136/ejhpharm-2021-eahpconf.14
https://doi.org/10.1136/ejhpharm-2021-eahpconf.14